{
    "2020-07-23": [
        [
            {
                "time": "2020-Q2",
                "original_text": "房地产业板块基金持仓点评：减配龙头 成长分化",
                "features": {
                    "keywords": [
                        "房地产",
                        "基金持仓",
                        "减配",
                        "成长分化"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "房地产"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-Q2",
                "original_text": "公募基金二季报回顾：仓位配置有望向“均衡”回归",
                "features": {
                    "keywords": [
                        "公募基金",
                        "二季报",
                        "仓位配置",
                        "均衡"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020",
                "original_text": "2020年公募基金中报点评：行情助推持仓回升 大幅加仓医药生物",
                "features": {
                    "keywords": [
                        "公募基金",
                        "中报",
                        "行情",
                        "持仓回升",
                        "医药生物"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-W28",
                "original_text": "天风总量团队每周论势第28期：如何看待当前市场位置？",
                "features": {
                    "keywords": [
                        "天风总量",
                        "市场位置",
                        "每周论势"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "50股获券商买入评级 创世纪目标涨幅达83.17%",
                "features": {
                    "keywords": [
                        "券商买入评级",
                        "创世纪",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "个股"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}